ATE55988T1 - Dihydropyridinderivat, verfahren zu seiner herstellung und dieses enthaltende pharmazeutische zusammensetzung. - Google Patents

Dihydropyridinderivat, verfahren zu seiner herstellung und dieses enthaltende pharmazeutische zusammensetzung.

Info

Publication number
ATE55988T1
ATE55988T1 AT86113538T AT86113538T ATE55988T1 AT E55988 T1 ATE55988 T1 AT E55988T1 AT 86113538 T AT86113538 T AT 86113538T AT 86113538 T AT86113538 T AT 86113538T AT E55988 T1 ATE55988 T1 AT E55988T1
Authority
AT
Austria
Prior art keywords
dihydropyride
derivative
preparation
pharmaceutical composition
composition containing
Prior art date
Application number
AT86113538T
Other languages
German (de)
English (en)
Inventor
Giuseppe Quadro
Jean Cahn
Original Assignee
Yason Srl
Sir International Sa
Henning Berlin Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yason Srl, Sir International Sa, Henning Berlin Gmbh filed Critical Yason Srl
Application granted granted Critical
Publication of ATE55988T1 publication Critical patent/ATE55988T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
AT86113538T 1985-10-04 1986-10-01 Dihydropyridinderivat, verfahren zu seiner herstellung und dieses enthaltende pharmazeutische zusammensetzung. ATE55988T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT22364/85A IT1201476B (it) 1985-10-04 1985-10-04 Derivato diidropiridinico,procedimento per la sua preparazione e composizioni farmaceutiche che lo contengono
EP86113538A EP0218996B1 (en) 1985-10-04 1986-10-01 Dihydropyridine derivative, a process for the production thereof and pharmaceutical compositions therefrom

Publications (1)

Publication Number Publication Date
ATE55988T1 true ATE55988T1 (de) 1990-09-15

Family

ID=11195258

Family Applications (1)

Application Number Title Priority Date Filing Date
AT86113538T ATE55988T1 (de) 1985-10-04 1986-10-01 Dihydropyridinderivat, verfahren zu seiner herstellung und dieses enthaltende pharmazeutische zusammensetzung.

Country Status (7)

Country Link
US (1) US4826856A (enrdf_load_stackoverflow)
EP (1) EP0218996B1 (enrdf_load_stackoverflow)
JP (1) JPS62161758A (enrdf_load_stackoverflow)
AT (1) ATE55988T1 (enrdf_load_stackoverflow)
DE (1) DE3673744D1 (enrdf_load_stackoverflow)
ES (1) ES2017613B3 (enrdf_load_stackoverflow)
IT (1) IT1201476B (enrdf_load_stackoverflow)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT388731B (de) * 1987-12-15 1989-08-25 Gerot Pharmazeutika Neue derivate von benzimidazol, ihre herstellung und verwendung
US5089502A (en) * 1989-06-02 1992-02-18 E. R. Squibb & Sons, Inc. Method for preventing or treating anxiety employing a calcium channel blocker
CA2016465A1 (en) * 1989-06-02 1990-12-02 Zola Phillip Horovitz Method for preventing or treating anxiety employing a calcium channel blocker

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2218644C3 (de) * 1972-04-18 1982-08-19 Bayer Ag, 5090 Leverkusen Basische Ester von 1,4-Dihydropyridinen, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel
US4031104A (en) * 1972-04-18 1977-06-21 Bayer Aktiengesellschaft 1,4-Dihydropyridine carboxylic acid esters
JPS57175166A (en) * 1981-04-23 1982-10-28 Banyu Pharmaceut Co Ltd Carbamoyloxyalkyl-1,4-dihydropyridine derivative and its preparation

Also Published As

Publication number Publication date
JPH0480026B2 (enrdf_load_stackoverflow) 1992-12-17
IT1201476B (it) 1989-02-02
JPS62161758A (ja) 1987-07-17
US4826856A (en) 1989-05-02
EP0218996B1 (en) 1990-08-29
EP0218996A3 (en) 1988-09-21
IT8522364A0 (it) 1985-10-04
ES2017613B3 (es) 1991-03-01
EP0218996A2 (en) 1987-04-22
DE3673744D1 (de) 1990-10-04

Similar Documents

Publication Publication Date Title
ATE119905T1 (de) Makrolide antibiotika und verfahren zu deren herstellung.
KR900016220A (ko) 매크로리드 조성물
DZ1468A1 (fr) Composés nouveaux.
MY117090A (en) Substituted benzamidines, their preparation and their use as pharmaceutical compounds
ATE46146T1 (de) Phenylpiperidinderivat und seine salze, ihre herstellung, sie enthaltende zusammensetzungen und ihre therapeutische verwendung.
NZ231295A (en) Substituted alpha,omega-aminoalcohols and process for the preparation thereof
DE69020781D1 (de) Gallensäure-Derivate, Verfahren zu deren Herstellung und pharmazeutische Zusammensetzungen daraus.
EP0749305A4 (en) METHOD FOR PRODUCING AVERMECTIN / ZEIN COMPOSITIONS
HUP9701660A2 (hu) 10,13,15-trioxa-triciklo[9.2.1.1. 9.6]pentadekanon-származékok, eljárás ezek előállítására, és az e vegyületeket tartalmazó gyógyászati készítmények
ATE55988T1 (de) Dihydropyridinderivat, verfahren zu seiner herstellung und dieses enthaltende pharmazeutische zusammensetzung.
KR860002508A (ko) 푸로(3,2-c)피리딘 유도체, 그의 제법 및 그를 포함하는 의약 조성물
FI915875L (fi) Menetelmä yleisen kaavan I mukaisten lääkeaineina käyttökelpoisten 2,3-dihydro-4H-1,3-bentsoksatsinon-4-onien ja 2,3-dihydro-4H-bentsotiatsinon-4-onien nitro-oksijohdannaisten valmistamiseksi
KR870004038A (ko) 제초제 화합물의 제조방법
TW339325B (en) Novel azepane derivatives, process for the preparation thereof and pharmaceutical composition containing the same
HK18082A (en) Hexahydroazepine, piperidine and pyrrolidine derivatives
EP0367671A3 (en) Novel beta-d-phenylthioxylosides, their method of preparation and their use as pharmaceuticals
ES472295A1 (es) Procedimiento de obtencion de nuevas acilureas con actividadfarmacologica
ES8608887A1 (es) Procedimiento para la obtencion de preparados combinados antihipertensores y antianginicos a base de dihidropiridina y bloquear beta.
JPS6438067A (en) 1,4-dihydropyridine derivative labeled with deuterium
KR940021524A (ko) 1,2,5,6-테트라하이드로피리딘 유도체와 이의 제조 방법 및 치료시 이의 이용방법
ATE55768T1 (de) Substituierte alkylamino-derivate von 6,11dihydro-11-oxo-dibenz(b,e)-oxepin, verfahren zu ihrer herstellung, ihre zwischenprodukte und ihre verwendung als arzneimittel.
KR960022533A (ko) 리파마이신 유도체의 제조방법
ATE63544T1 (de) 4-cyanopiperidine-derivate, herstellung und anwendung.
JPS5653654A (en) Preparation of novel aniline derivative
JPS57140783A (en) 1-benzyl-4-(4-(2-pyrimidinylamino)benzyl)-2, 3-dioxopiperazine derivative and its salt, their preparation, and carcinostatic agent containing the same